Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy -Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients Blayney, D., Ogenstad, S., Shi, Y., Zhang, Q., Du, L., Huang, L., Mohanlal, R. ELSEVIER SCIENCE INC. 2018: S461

View details for DOI 10.1016/j.jtho.2018.08.562

View details for Web of Science ID 000454014501196